Replay available

QuidelOrtho Corporation (QDEL) Q3 2025 Earnings Call

QuidelOrtho Corporation (NASDAQ: QDEL) Q3 2025 earnings conference call, held 2025-11-05. Replay captured from the company's public earnings webcast.

Wed, November 5, 2025 at 5:00 PMendedReplay
QuidelOrtho Corporation (QDEL) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Juliet Cunningham

Vice President of Investor Relations

Brian Blazer

President and Chief Executive Officer

Joe Buskey

Chief Financial Officer

Andrew Brockman

Analyst, William Blair

Lou Lee

Analyst, UBS

Jack Meehan

Analyst, Nefron Research

Tycho Peterson

Analyst, Jefferies

Andrew Cooper

Analyst, Raymond James

Replay transcript excerpt

Welcome to the Quidel Ortho third quarter 2025 financial results conference call and webcast. At this time, all participant lines are in a listen-only mode. For those of you participating in the conference call, there will be an opportunity for your questions at the end of today's prepared remarks. Please note this conference call is being recorded. An audio replay of the conference call will be available on the company's website shortly after this call. I would now like to turn the call over to Juliet Cunningham, Vice President of Investor Relations. Thank you. Good afternoon, everyone. Thanks for joining the Quidel Third Quarter 2025 Financial Results Conference Call. Joining me today are Brian Blazer, President and Chief Executive Officer, and Joe Buskey, Chief Financial Officer. This conference call is being simultaneously webcast on the Investor Relations page of our website. To assist in the presentation, we also posted supplemental information on the investor relations page that will be referenced throughout this call. This conference call and supplemental information contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not strictly historical, including the company's expectations, plans, financial guidance, and future performance and prospects are forward-looking statements that are subject to certain risks, uncertainty, assumptions, and other factors. This includes the expected impact of tariffs and macroeconomic conditions and the proposed acquisition of lex diagnostics. Actual results may vary materially from those expressed or implied in these forward-looking statements. Information about potential factors that could affect our actual results is available on our annual report on...

More from Quidelortho Corporation